Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers

Summary

This is a single-center, open-label, single-dose study. The primary objective is to determine Epithelial Lining Fluid (ELF) levels of ME1100 after a single orally inhaled dose. The secondary objectives are to determine systemic exposure to inhaled ME1100 and to assess tolerability and safety of a single dose of ME1100 inhalation solution.

Timeline

Start

2013-09

Primary completion

2013-12

Completion

—

Drugs

Indications

No indication recorded.